Key result
Autonomic nervous system dysfunctions frequently accompany chronic diseases, and decreasing dysautonomia intensity may directly improve the underlying disease progress and general health.
Autonomic nervous system dysfunctions should be considered at each stage of the diagnostic and treatment processes for chronic diseases as a predictor of the patient's clinical condition.
Answers are grounded in this paper and cite their sources.
May support autonomic screening in chronic disease care; leaves open whether interventions alter progression.
Introduction: The majority of chronic diseases are accompanied by symptoms of more or less pronounced dysautonomia, which frequently and noticeably deteriorate the quality of patients' life. Sources of data: Pubmed. Areas of agreement: Functional disorders in the autonomic nervous system (ANS) require very precise diagnostics; frequently involving several specialists and a number of diagnostic tests. Areas of controversy: Dysautonomia symptoms are of a very discrete nature and may develop much earlier than symptoms specific for a given chronic disease, significantly influencing the treatment process itself. Growing points: ANS dysfunctions should be considered at each stage of the diagnostic and treatment processes, as a predictor for the patient's clinical condition. Areas timely for developing research: Many researchers indicate that a decrease in dysautonomia intensity has a direct effect on the progress of the underlying disease and undoubtedly contributes to the improvement of the general health condition or to symptoms remission.
No takes yet. Share an insight, caveat, or question.
Zalewski et al. (2018) conducted a review in Chronic diseases with dysautonomia. Autonomic nervous system dysfunctions frequently accompany chronic diseases, and decreasing dysautonomia intensity may directly improve the underlying disease progress and general health.
Synapse has enriched 10 related papers. Consider them for comparative context: